These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of the endothelin receptor antagonist Bosentan on ischaemia/reperfusion injury in rat skeletal muscle. Herbert KJ; Hickey MJ; Lepore DA; Knight KR; Morrison WA; Stewart AG Eur J Pharmacol; 2001 Jul; 424(1):59-67. PubMed ID: 11470261 [TBL] [Abstract][Full Text] [Related]
4. Effect of the endothelin receptor antagonist bosentan on postischemic oxygen supply of the liver. Spiegel HU; Uhlmann D; Scommotau S; Giersch B; Sulkowski U J Invest Surg; 1996; 9(6):439-45. PubMed ID: 8981217 [TBL] [Abstract][Full Text] [Related]
5. Important role for endothelins in acute hepatic ischemia/reperfusion injury. Uhlmann D; Uhlmann S; Spiegel HU J Invest Surg; 2001; 14(1):31-45. PubMed ID: 11297059 [TBL] [Abstract][Full Text] [Related]
7. Bosentan, an endothelin antagonist, augments hepatic graft function by reducing graft circulatory impairment following ischemia/reperfusion injury. Ricciardi R; Schaffer BK; Shah SA; Quarfordt SH; Banner BF; Wheeler SM; Donohue SE; Meyers WC; Chari RS J Gastrointest Surg; 2001; 5(3):322-9. PubMed ID: 11360057 [TBL] [Abstract][Full Text] [Related]
8. Endothelin receptor blockade as a therapeutic strategy in ameliorating postischemic damage to the liver microcirculation. Uhlmann D; Uhlmann S; Palmes D; Spiegel HU J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S351-3. PubMed ID: 11078418 [TBL] [Abstract][Full Text] [Related]
9. Blockade of endothelin receptors with bosentan limits ischaemia/reperfusion-induced injury in rat ovaries. Sengul O; Ferah I; Polat B; Halici Z; Bayir Y; Yilmaz M; Kilic N; Keles ON Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):458-63. PubMed ID: 23880599 [TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischaemia/reperfusion in the rat. Li XS; Wang QD; Pernow J Eur J Pharmacol; 1995 Sep; 283(1-3):161-8. PubMed ID: 7498305 [TBL] [Abstract][Full Text] [Related]
11. Effects of mixed ETA and ETB-receptor antagonist (Ro-47-0203) on hepatic microcirculation after warm ischemia. Koeppel TA; Kraus T; Thies JC; Gebhard MM; Otto G; Post S Dig Dis Sci; 1997 Jun; 42(6):1316-21. PubMed ID: 9201101 [TBL] [Abstract][Full Text] [Related]
12. Role of endothelin during reperfusion after ischemia in isolated perfused rat heart. Dagassan PH; Breu V; Clozel M; Clozel JP J Cardiovasc Pharmacol; 1994 Dec; 24(6):867-74. PubMed ID: 7898067 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological regulation of postischemic sinusoidal diameters in rats--a new approach for reducing hepatic ischemia/reperfusion injury. Uhlmann D; Uhlmann S; Löffler BM; Witzigmann H; Spiegel HU Clin Hemorheol Microcirc; 2001; 24(4):233-46. PubMed ID: 11564912 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the protective effects of selective endothelin-a receptor antagonist, ambrisentan, and dual endothelin-A/B receptor antagonist, bosentan, in experimental renal ischemia reperfusion injury. Kazimoglu H; Uysal E; Dokur M; Gurer AO; Batcioglu K; Uyumlu BA; Petekkaya E; Karadag M Bratisl Lek Listy; 2020; 121(8):547-553. PubMed ID: 32726116 [TBL] [Abstract][Full Text] [Related]
15. Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist. Richard V; Kaeffer N; Hogie M; Tron C; Blanc T; Thuillez C Br J Pharmacol; 1994 Nov; 113(3):869-76. PubMed ID: 7858879 [TBL] [Abstract][Full Text] [Related]
16. Coronary and aortic vasoreactivity protection with endothelin receptor antagonist, bosentan, after ischemia and hypoxia in aged rats. Besse S; Tanguy S; Riou B; Boucher F; Bulteau AL; Le Page C; Swynghedauw B; de Leiris J Eur J Pharmacol; 2001 Dec; 432(2-3):167-75. PubMed ID: 11740953 [TBL] [Abstract][Full Text] [Related]
17. Endothelin A and B receptor antagonist bosentan reduces postischemic myocardial injury in the rat: critical timing of administration. Xia Z; Kuo KH; McNeill JH; Ansley DM Can J Physiol Pharmacol; 2005 Mar; 83(3):259-66. PubMed ID: 15870840 [TBL] [Abstract][Full Text] [Related]